Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.
about
Central memory CD8+ T lymphocytes mediate lung allograft acceptance.High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy.Calcineurin regulates myocardial function during acute endotoxemiaInducible nitric oxide synthase (NOS-2) in subarachnoid hemorrhage: Regulatory mechanisms and therapeutic implications.Hydrogen peroxide induces overexpression of angiotensin-converting enzyme in human umbilical vein endothelial cells.Modulation of Human Immune Response by Fungal Biocontrol Agents.Early steps of microglial activation are directly affected by neuroprotectant FK506 in both in vitro inflammation and in rat model of stroke.Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.Effect of cyclosporin A on nitric oxide production in cultured LLC-PK1 cells.DNA damage and oxidative status in newly diagnosed, untreated, dipper and non-dipper hypertensive patients.Tacrolimus (FK506) and cyclosporin A reduce macrophage recruitment to the rat brain injured at perinatal and early postnatal periods.Role of penile vascular insufficiency in erectile dysfunction in renal transplant recipients.The calcineurin inhibitor cyclosporine A improves lipopolysaccharide-induced vascular dysfunction but does not rescue from cardiovascular collapse in endotoxemic mice.
P2860
Q30573064-90B3D256-3E24-4D3B-9EB6-4B4747B4B341Q35952116-3E56BBFD-27DF-4828-B416-6022AB96E0E8Q35979818-BDD51A20-3F02-4274-BF5C-8461A6062C28Q37144330-D39553A8-C7BF-47ED-893A-C85293544A09Q37357824-1752F0F6-DF72-4CA9-8987-4649F2414F52Q38319965-8090EE9B-DF54-4301-A912-9608D1C390E6Q39143535-4BB316C7-1B47-4A2A-A5D9-7D9F556248E4Q42024053-EB07A818-13A9-40AD-95A7-125EBF65E44CQ42129809-E2DBA7C1-FD35-4F1B-89AD-BFF287A5B441Q42501379-9CB413AD-9B6C-4126-A543-1A4340C478C6Q43422650-0C9D1128-B457-4824-A6BE-02B5ABD7526EQ43658737-174A4657-4677-417D-ADDB-A93C53DC6B8FQ43918996-538872F8-E7F6-4165-82B4-42C7C0FE5154Q50978276-B22777D6-9AFD-4089-856D-5DD227406260
P2860
Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Cyclosporin A and tacrolimus ( ...... vitro by different mechanisms.
@en
type
label
Cyclosporin A and tacrolimus ( ...... vitro by different mechanisms.
@en
prefLabel
Cyclosporin A and tacrolimus ( ...... vitro by different mechanisms.
@en
P2093
P2860
P356
P1476
Cyclosporin A and tacrolimus ( ...... vitro by different mechanisms.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0702782
P407
P577
1999-09-01T00:00:00Z